Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice.

Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice.

The adipokine chemerin and its receptor, chemokine-like receptor 1 (Cmklr1), are associated with insulin resistance and nonalcoholic fatty liver disease (NAFLD), which covers a broad spectrum of liver diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). It is possible that...

Full description

Bibliographic Details
Main Authors: Nanda Gruben, Marcela Aparicio Vergara, Niels J Kloosterhuis, Henk van der Molen, Stefan Stoelwinder, Sameh Youssef, Alain de Bruin, Dianne J Delsing, Jan Albert Kuivenhoven, Bart van de Sluis, Marten H Hofker, Debby P Y Koonen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096345&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096345&type=printable

Similar Items